EU funds study on genetics/environment and asthma

14 May 2006

German and English scientists will lead a Europe-wide study into the role of genetics and the environment in the development of asthma. Previous investigations have fallen short of proving cause-effect due to the complexity of human genetics and varying lifestyles. But the European Union-funded GABRIEL study has pooled the very best in the field from all over Europe and can draw on the latest genomic and environmental data and approaches.

Evidence that exposure to microbes in rural farming environments results in a lower incidence of asthma is going to be investigated by GABRIEL.

Imperial College London and Munich University are leading an 11.0 million-euros ($14.0 million) investigation into how genetics and the environment influence the development of asthma in Europe. The Sixth Framework Program-funded project GABRIEL involves over 150 scientists from 14 European countries, using the latest research across a variety of disciplines, including genetics, epidemiology and immunology, to identify key factors in the development of asthma.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight